| A method for the confirmation and quantitation of benzoylecgonine in urine using the DSQTM II GC/MS system was fully validated. This validation covered precision, specificity/interference, linearity and carryover. All work was performed on extracted, derivatized urine samples to mirror real-world requirements. This application note highlights key results from these validation studies. The DSQ II and ToxLabTM 2.0 software provide reliable, robust performance for the routine GC/MS confirmation of benzoylegonine in urine.
Click on the link to the left to download this application note.
For comprehensive method information and detailed results from all phases of the validation studies, click here to download the technical note. |
0 Items 